Argentina offers one of the few places on earth where oil companies are not suffering from the full force of the collapse in prices. Argentina regulates oil prices, a policy originally intended to insulate the public from the whims of
March 12, 2016
Man-oh-man, the heat I am taking over my recent “Caution” stance on the near-term outlook for gold and silver is now verging on the theatre of the absurd. Email, tweets, voicemail messages and every other form of indirect confrontation have
The US Daily Cash Deficit for Thursday 3/10/2016 was $5.9B bringing the March 2016 deficit through 10 days to $92B. Revenue looks down big….you may recall that last March received about $35B of additional revenue thanks to the FCC wireless
After the wild ECB storm, another busy week awaits. And it’s not only about the Fed. Here is the preview from Bank of America Merrill Lynch: Here is their view, courtesy of eFXnews: Based on Fed speakers since the January
There is a long running feud between investors who believe in investing for total return versus those who believe in investing for current income. Both camps are fervent advocates of their respective beliefs, and there seems to be no feasible
The weakness in the global financial markets has helped precious metals, like gold and silver, to recover their sheen in 2016. Sluggish growth in China since the beginning of the year and the global oil market turbulence has lifted safe-haven
I recently welcomed bestselling author of “The Devil’s Financial Dictionary” and Wall Street Journal columnist Jason Zweig to our North American headquarters. Via by Shai Dardashti, Latticework In Jason’s own words: Origins of The Devil’s Financial Dictionary Writing The Devil’s Financial Dictionary
While the markets have cheered the public admission that the central banks have completely failed in their quantitative easing and they will now buy more for longer, the technical profile is not as buoyant as it might appear on the
Deals and Financings Hutchison China MediTech (Chi-Med) (AIM: HCM), a company developing novel drugs for oncology and autoimmune diseases, is scheduled to raise $100 million by listing ADS shares on the NASDAQ exchange (see story). The offering values Chi-Med at $1.9
The Commitment of Traders reporting period ending March 8 showed little position adjusting ahead of the ECB meeting two days later. A little more than 3/4 of the gross positions we track saw less than 5k contract change and only two
